Publications

May 01, 2011

How does type 1 diabetes develop?: The notion of homicide or β-cell suicide revisited

Atkinson MA, Bluestone JA, Eisenbarth GS, Hebrok M, Herold KC, Accili D, Peitropaolo M, Arvan PR, von Herrath M, Markel DS, Rhodes CJ
May 01, 2011

Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?

Christen U, von Herrath MG
May 01, 2011

TLR2 signaling improves immunoregulation to prevent type 1 diabetes

Filippi CM, Ehrhardt K, Estes EA, Larsson P, Oldham JE, von Herrath MG
Apr 01, 2011

Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay

Diana J, Brezar V, Beaudoin L, Dalod M,Mellor A, Tafuri A, von Herrath M, Boitard C, Mallone R, Lehuen A
Mar 01, 2011

Anti-thymoglobulin (ATG) treatment does not reverse type 1 diabetes in the acute virally induced rat insulin promoter-lymphocytic choriomeningitis virus (RIP-LCMV) model

Bresson D, von Herrath MG
Feb 01, 2011

Humanizing animal models: a key to autoimmune diabetes treatement

Bresson D, von Herrath M
Jan 01, 2011

Type 1 diabetes vaccine development: animal models vs. humans

Boettler T, von Herrath M
Jan 01, 2011

Protection against or triggering of Type 1 diabetes? Different roles for viral infections

Boettler T, von Herrath M
Jan 01, 2011

Beta cells under attack: toward a better understanding of type 1 diabetes immunopathology

Coppieters KT, Roep BO, von Herrath MG
Jan 01, 2011

Increased memory conversion of naïve CD8 T cells activated during late phases of acute virus infection due to decreased cumulative antigen exposure

Fousteri G, Dave A, Juedes A, Juntti T, Morin B, Togher L, Farber DL, von Herrath M
Jan 01, 2011

Type 1 diabetes: etiology, immunology, and therapeutic strategies

Van Belle TL, Coppieters KT, von Herrath MGVan Belle TL, Coppieters KT, von Herrath MG
Boettler T, von Herrath MG